Brazil’s health regulator said it had suspended clinical trials of a Chinese-developed Covid-19 vaccine after an “adverse incident” involving a volunteer recipient, a blow for one of the most advanced vaccine candidates. The setback for CoronaVac, developed by China’s Sinovac Biotech, came on Monday as US pharmaceutical giant Pfizer said its own vaccine candidate had […]
